Literature DB >> 7288405

Antigen and polypeptide synthesis by temperature-sensitive mutants of respiratory syncytial virus.

C R Pringle, P V Shirodaria, H B Gimenez, S Levine.   

Abstract

A revised nomenclature for the polypeptides of respiratory syncytial (RS) virus has been devised on the basis of comparison of the Long, A2 and RSN-2 strains by slab-gel electrophoresis. Seven polypeptides, now designated VP200, VGP48, VPN41, VPP32, VPM27, VP25 and VP10, were observed in preparations of all three strains of RS virus, irrespective of the host cell of origin. In addition, a slowly migrating glycopolypeptide GP1 was prominent in partially purified RS virus of the Long and A2 strains obtained from Hep-2 cells, and to a lesser extent from BS-C-1 cells. In the case of the RSN-2 strain, this polypeptide was only resolved clearly in virus obtained from Hep-2 cells. GP1 was an atypical glycopolypeptide in that 35S-methionine incorporation was poor relative to 3H-glucosamine incorporation. The ts mutants of RS virus exhibited four distinct phenotypes with respect to intracellular polypeptide synthesis and antigen production of 39 degrees C. Mutants ts 17 (complementation group B') and ts 19 (group E) were almost completely restricted, suggesting defective early functions. Mutants ts A1 (group A), ts A7 (group C) and ts 1 (group D) synthesized antigen and polypeptides normally, but the amount of antigen at the cell surface was reduced, suggesting maturation defects. In addition, the VPP32 of ts 1 (group D) exhibited an aberrant mobility, confirming its viral specificity. The remaining mutants, representing groups B, F and G exhibited generally impaired synthesis at 39 degrees C. Absence of surface filaments in ts mutant-infected cells at 39 degrees C confirmed their virus-specific nature.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7288405     DOI: 10.1099/0022-1317-54-1-173

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  A single amino acid substitution in the phosphoprotein of respiratory syncytial virus confers thermosensitivity in a reconstituted RNA polymerase system.

Authors:  A C Marriott; S D Wilson; J S Randhawa; A J Easton
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Transcription of human respiratory syncytial virus genome RNA in vitro: requirement of cellular factor(s).

Authors:  S Barik
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Calcium requirement for syncytium formation in HEp-2 cells by respiratory syncytial virus.

Authors:  M S Shahrabadi; P W Lee
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

4.  cDNA cloning and transcriptional mapping of nine polyadenylylated RNAs encoded by the genome of human respiratory syncytial virus.

Authors:  P L Collins; G W Wertz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

Review 5.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

6.  Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein.

Authors:  E E Walsh; J Hruska
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

7.  The genome of respiratory syncytial virus is a negative-stranded RNA that codes for at least seven mRNA species.

Authors:  Y T Huang; G W Wertz
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

8.  Effect of changes in the nucleotide sequence of the P gene of respiratory syncytial virus on the electrophoretic mobility of the P protein.

Authors:  C Caravokyri; C R Pringle
Journal:  Virus Genes       Date:  1992-01       Impact factor: 2.332

9.  Analysis of proteins synthesized in respiratory syncytial virus-infected cells.

Authors:  E J Dubovi
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

10.  The envelope-associated 22K protein of human respiratory syncytial virus: nucleotide sequence of the mRNA and a related polytranscript.

Authors:  P L Collins; G W Wertz
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.